Monges Viviane 4
4 · ADC Therapeutics SA · Filed Jun 3, 2026
Research Summary
AI-generated summary of this filing
ADC Therapeutics (ADCT) Director Viviane Monges Receives Award
What Happened Viviane Monges, a director of ADC Therapeutics (ADCT), received an award of 45,000 restricted stock units (RSUs) on 2026-06-01 (code A). The RSUs were granted at $0.00 per share as an equity award. On 2026-06-03 the issuer withheld 2,596 common shares (code F) to satisfy tax withholding obligations related to RSU vesting; those shares were recorded as disposed at $3.08 each, totaling approximately $7,996. This is a standard director equity grant plus routine tax-withholding, not an open-market purchase or sale for investment.
Key Details
- Transactions reported:
- 2026-06-01 — Award (A): 45,000 RSUs granted @ $0.00 (each RSU = contingent right to 1 share).
- 2026-06-03 — Tax withholding (F): 2,596 shares withheld/disposed @ $3.08 = $7,996.
- Vesting terms (footnote): RSUs vest on the earlier of one year from grant or the 2027 Annual Meeting, subject to continued service (F1).
- Withholding note (footnote): The 2,596 shares were withheld by the issuer to satisfy the reporting person’s tax obligations on RSU vesting (F2).
- Shares owned after the transactions: not specified in the provided filing excerpt.
- Filing date: Form 4 filed 2026-06-03; timing appears routine for the reported transactions (no late-filing indication in the excerpt).
Context
- RSU awards are compensation-based grants that convert to stock if/when they vest and are not the same as a market purchase (so they don’t necessarily signal a director’s personal bullish stance).
- The withholding of shares to pay taxes is a common administrative step (reduces net shares received).
Insider Transaction Report
Form 4
Monges Viviane
Director
Transactions
- Award
Common Shares
[F1]2026-06-01+45,000→ 189,043 total - Tax Payment
Common Shares
[F2]2026-06-03$3.08/sh−2,596$7,996→ 186,447 total
Footnotes (2)
- [F1]Represents the annual grant of restricted stock units ("RSUs") made under the Issuer's 2019 Equity Incentive Plan for service as a Director. The RSUs vest on the earlier of (i) one year from the grant date or (ii) the date of the 2027 Annual Meeting of Shareholders, subject to the Reporting Person's continued service to the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- [F2]Represents the number of Common Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted share units previously granted.
Signature
/s/ Lisa Kallebo, as Attorney-in-Fact for Viviane Monges|2026-06-03